Penile cancer
Prepared with OnCo (onco.cc/prep/penile/). Orientation, not medical advice; your team knows your case.
My details
What I know, what is unclear, changes to discuss
Saved in this browserMy questions
15 on the sheet- 1.What is my exact diagnosis, stage, and grade, and which tests established them?
- 2.Which biomarkers have been tested on my tumour (for example p16 IHC / HPV DNA status, Grade and lymphovascular invasion of the primary, Inguinal and pelvic nodal stage, PD-L1 expression, TP53 and CDKN2A status), and what were the results?
- 3.Which subtype is my cancer, and does that change the recommended treatment?
- 4.Is germline (inherited) genetic testing recommended for me or my family?
- 5.For my situation (primary tumour), which of the standard options do you recommend and why?
- 6.For my situation (clinically node-negative, intermediate or high-risk primary), which of the standard options do you recommend and why?
- 7.For my situation (node-positive), which of the standard options do you recommend and why?
- 8.Am I a candidate for Paclitaxel / nab-paclitaxel, Cisplatin, Ifosfamide, and what side effects should I expect?
- 9.For my situation (metastatic or recurrent), which of the standard options do you recommend and why?
- 10.Am I a candidate for Cisplatin, Paclitaxel / nab-paclitaxel, Pembrolizumab or related drugs, and what side effects should I expect?
- 11.Are there clinical trials I could join, for example of Pembrolizumab, Cemiplimab, HPV & HBV vaccination?
- 12.Would a second opinion at a high-volume centre change anything, and can you help arrange it?
- 13.What supportive care (symptom control, nutrition, exercise, mental health, financial help) is available from the start?
- 14.I read that “Node-positive disease: the best sequence of chemotherapy, radiotherapy and surgery is unknown; InPACT is designed to answer it”. How does that affect my plan?
- 15.I read that “No approved systemic therapy beyond cisplatin combinations; checkpoint inhibitor trials (often HPV-stratified) are recruiting”. How does that affect my plan?
The words I may hear
- Mohs surgery: Skin cancer surgery in which the tumour is removed in thin layers, each checked under the microscope on the spot, until the edges are clear; it spares the most normal skin.
- Lymphadenectomy (lymph node dissection): Surgically removing the lymph nodes that drain a tumour, both to stage the cancer and to clear any spread.
- HPV status (HPV-positive / HPV-negative): Whether a cancer is caused by human papillomavirus.
- HPV-positive (p16) head and neck cancer: Throat cancers caused by the human papillomavirus, identified by a p16 stain.
Tests and results to bring
Biomarker results to ask for: p16 IHC / HPV DNA status, Grade and lymphovascular invasion of the primary (decides sentinel node biopsy), Inguinal and pelvic nodal stage (extranodal extension, number of nodes), PD-L1 expression (investigational), TP53 and CDKN2A status (HPV-independent tumours).
Bring copies of scan reports, pathology and blood results, and a list of every medicine and supplement.
The treatments I may be offered
- Primary tumour: Organ-sparing treatment where feasible (glansectomy, glans resurfacing, wide local excision, laser or brachytherapy); partial or total penectomy reserved for extensive tumours. (Brachytherapy, Mohs surgery)
- Clinically node-negative, intermediate or high-risk primary: Dynamic sentinel node biopsy (or modified inguinal lymphadenectomy where unavailable); observation only for low-risk primaries. (Sentinel lymph node biopsy)
- Node-positive: Radical inguinal lymphadenectomy; pelvic lymphadenectomy and adjuvant chemotherapy or chemoradiation for extensive disease; neoadjuvant TIP for bulky or fixed nodes (InPACT is testing the sequence). (Lymphadenectomy (lymph node dissection), Paclitaxel / nab-paclitaxel, Cisplatin, Ifosfamide)
- Metastatic or recurrent: Cisplatin-based chemotherapy (TIP); checkpoint inhibitors in trials or where approved for tumour-agnostic indications; palliative radiotherapy. (Cisplatin, Paclitaxel / nab-paclitaxel, Pembrolizumab, Cemiplimab)
From the standard of care recorded for this cancer; which apply depends on your stage and biomarkers. Ask which the team recommends and why.